Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

MKSAP: 33-year-old woman with amenorrhea and galactorrhea

mksap
Conditions
February 8, 2014
Share
Tweet
Share

Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians.

A 33-year-old woman is evaluated for a 5-month history of amenorrhea and a 3-month history of galactorrhea. The patient says her menstrual cycles were normal before onset of amenorrhea. She takes no medication.

On physical examination, vital signs are normal. Visual field findings are normal. Bilateral galactorrhea is noted.

Results of laboratory studies show a serum luteinizing hormone level of 2 mU/mL (2 units/L), a prolactin level of 965 ng/mL (965 µg/L), and a free thyroxine level of 1.1 ng/dL (14 pmol/L). A serum β-human chorionic gonadotropin measurement is normal.

An MRI shows a 1.5-cm sellar mass with suprasellar extension that impinges on the optic chiasm.

Which of the following is the most appropriate initial treatment?

A: Dopamine agonist therapy
B: Oral contraceptive
C: Radiation therapy
D: Transsphenoidal surgical resection

MKSAP Answer and Critique

The correct answer is A: Dopamine agonist therapy. This item is available to MKSAP 16 subscribers as item 64 in the Endocrinology and Metabolism section.

This patient has a macroprolactinoma, and administration of a dopamine agonist, such as cabergoline, is indicated as the initial treatment. Hyperprolactinemia can cause galactorrhea, oligomenorrhea, and amenorrhea in premenopausal women; erectile dysfunction in men; and decreased libido, infertility, and osteopenia in both sexes. Large tumors also may cause mass effects, which are often the presenting feature in men and postmenopausal women. This patient has amenorrhea and galactorrhea in the setting of a markedly elevated serum prolactin level. The MRI shows a pituitary mass greater than 1 cm that extends to the optic chiasm. These radiographic findings are consistent with a macroprolactinoma with chiasmal compression. The visual field examination indicates that the mass is not currently compressing the chiasm to the point of visual loss. Dopamine agonists normalize prolactin levels, correct amenorrhea and galactorrhea, and decrease tumor size by more than 50% in 80% to 90% of patients. They are used as first-line therapy, unless visual field loss is significant and progressive. Even with mild visual loss, dopamine agonists are usually used as first-line treatment. Cabergoline is generally more efficacious and better tolerated, although more expensive, than bromocriptine.

An oral contraceptive agent will replace gonadal corticosteroids and lead to menstruation but will not reduce tumor size. Simple replacement of estrogen with oral contraceptives is inappropriate therapy in this patient but may be preferable treatment in women with idiopathic hyperprolactinemia or microprolactinomas who do not desire fertility but are estrogen deficient. Because prolactinomas have estrogen receptors, tumor growth resulting from estrogen replacement therapy is possible. However, with the dosages routinely used in oral contraceptives, this growth is very uncommon.

Surgery is appropriate only in patients with resistance or intolerance to dopamine agonists, with a primarily cystic tumor, or with acute and unstable deterioration of vision. Radiation therapy, including stereotactic radiosurgery, is used even less commonly for prolactinomas but is indicated for macroprolactinomas that do not respond to either medical or surgical treatment.

Key Point

  • In a patient with a macroprolactinoma, administration of a dopamine agonist, such as cabergoline, is indicated as the initial treatment.

This content is excerpted from MKSAP 16 with permission from the American College of Physicians (ACP). Use is restricted in the same manner as that defined in the MKSAP 16 Digital license agreement. This material should never be used as a substitute for clinical judgment and does not represent an official position of ACP. All content is licensed to KevinMD.com on an “AS IS” basis without any warranty of any nature. The publisher, ACP, shall not be liable for any damage or loss of any kind arising out of or resulting from use of content, regardless of whether such liability is based in tort, contract or otherwise.

Prev

Options for the injured older adult in the emergency room

February 7, 2014 Kevin 2
…
Next

Approach patients as one human caring for another

February 8, 2014 Kevin 2
…

ADVERTISEMENT

Tagged as: Endocrinology

Post navigation

< Previous Post
Options for the injured older adult in the emergency room
Next Post >
Approach patients as one human caring for another

ADVERTISEMENT

More by mksap

  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 26-year-old man with back pain

    mksap
  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 36-year-old man with abdominal cramping, diarrhea, malaise, and nausea

    mksap
  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 52-year-old woman with osteoarthritis of the right hip

    mksap

More in Conditions

  • How molecular discoveries are transforming preeclampsia prediction and care

    Thomas McElrath, MD, PhD and Kara Rood, MD
  • How neuroplasticity offers hope for complex PTSD

    Hannah Holmes
  • New treatments for enlarged prostate offer faster relief with fewer side effects

    Martina Ambardjieva, MD, PhD
  • How value-based care transforms chronic kidney disease management

    Timothy Pflederer, MD
  • Why telling kids to eat less and move more fails to address obesity

    Callia Georgoulis
  • Clinical ghosts and why they haunt our exam rooms

    Kara Wada, MD
  • Most Popular

  • Past Week

    • The shocking risk every smart student faces when applying to medical school

      Curtis G. Graham, MD | Physician
    • Why so many doctors secretly feel like imposters

      Ryan Nadelson, MD | Physician
    • High blood pressure’s hidden impact on kidney health in older adults

      Edmond Kubi Appiah, MPH | Conditions
    • Why rigorous training is vital for today’s surgeons

      Philip Alford, MD | Physician
    • The physician who turned burnout into a mission for change

      Jessie Mahoney, MD | Physician
    • Deep transcranial magnetic stimulation for depression [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • From rejection to resilience: a doctor’s rise through the Caribbean route

      Ryan Nadelson, MD | Education
    • Rethinking medical gatekeeping in the age of AI

      Justin Schrager, MD, MPH | Tech
    • Why physicians struggle with caregiving and how to cope with grace

      Jessie Mahoney, MD | Physician
    • How molecular discoveries are transforming preeclampsia prediction and care

      Thomas McElrath, MD, PhD and Kara Rood, MD | Conditions
    • Why agency and partnership are vital in modern health care

      Alan P. Feren, MD | Physician
    • How neuroplasticity offers hope for complex PTSD

      Hannah Holmes | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The shocking risk every smart student faces when applying to medical school

      Curtis G. Graham, MD | Physician
    • Why so many doctors secretly feel like imposters

      Ryan Nadelson, MD | Physician
    • High blood pressure’s hidden impact on kidney health in older adults

      Edmond Kubi Appiah, MPH | Conditions
    • Why rigorous training is vital for today’s surgeons

      Philip Alford, MD | Physician
    • The physician who turned burnout into a mission for change

      Jessie Mahoney, MD | Physician
    • Deep transcranial magnetic stimulation for depression [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • From rejection to resilience: a doctor’s rise through the Caribbean route

      Ryan Nadelson, MD | Education
    • Rethinking medical gatekeeping in the age of AI

      Justin Schrager, MD, MPH | Tech
    • Why physicians struggle with caregiving and how to cope with grace

      Jessie Mahoney, MD | Physician
    • How molecular discoveries are transforming preeclampsia prediction and care

      Thomas McElrath, MD, PhD and Kara Rood, MD | Conditions
    • Why agency and partnership are vital in modern health care

      Alan P. Feren, MD | Physician
    • How neuroplasticity offers hope for complex PTSD

      Hannah Holmes | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...